Processa Pharmaceuticals Statistics

Total Valuation

PCSA has a market cap or net worth of $2.17 million. The enterprise value is $831,801.

Market Cap	2.17M
Enterprise Value	831,801

Important Dates

The next estimated earnings date is Friday, May 9, 2025, after market close.

Earnings Date	May 9, 2025
Ex-Dividend Date	n/a

Share Statistics

PCSA has 5.27 million shares outstanding. The number of shares has increased by 133.30% in one year.

Current Share Class	5.27M
Shares Outstanding	5.27M
Shares Change (YoY)	+133.30%
Shares Change (QoQ)	+7.14%
Owned by Insiders (%)	8.68%
Owned by Institutions (%)	1.88%
Float	4.63M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	n/a
Forward PS	n/a
PB Ratio	0.81
P/TBV Ratio	1.15
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 1.22, with a Debt / Equity ratio of 0.04.

Current Ratio	1.22
Quick Ratio	0.78
Debt / Equity	0.04
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	n/a

Financial Efficiency

Return on equity (ROE) is -354.51% and return on invested capital (ROIC) is -218.02%.

Return on Equity (ROE)	-354.51%
Return on Assets (ROA)	-167.08%
Return on Invested Capital (ROIC)	-218.02%
Return on Capital Employed (ROCE)	-710.29%
Revenue Per Employee	n/a
Profits Per Employee	-$911,548
Employee Count	13
Asset Turnover	n/a
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -82.54% in the last 52 weeks. The beta is 1.04, so PCSA's price volatility has been similar to the market average.

Beta (5Y)	1.04
52-Week Price Change	-82.54%
50-Day Moving Average	0.54
200-Day Moving Average	1.15
Relative Strength Index (RSI)	37.16
Average Volume (20 Days)	106,304

Short Selling Information

The latest short interest is 95,265, so 1.81% of the outstanding shares have been sold short.

Short Interest	95,265
Short Previous Month	133,159
Short % of Shares Out	1.81%
Short % of Float	2.06%
Short Ratio (days to cover)	0.93

Income Statement

Revenue	n/a
Gross Profit	n/a
Operating Income	-12.05M
Pretax Income	-9.83M
Net Income	-11.85M
EBITDA	-12.05M
EBIT	-12.05M
Earnings Per Share (EPS)	-$3.87

Full Income Statement

Balance Sheet

The company has $1.19 million in cash and $73,507 in debt, giving a net cash position of $1.12 million or $0.21 per share.

Cash & Cash Equivalents	1.19M
Total Debt	73,507
Net Cash	1.12M
Net Cash Per Share	$0.21
Equity (Book Value)	1.70M
Book Value Per Share	0.46
Working Capital	340,988

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -$11.25 million and capital expenditures -$3,244, giving a free cash flow of -$11.25 million.

Operating Cash Flow	-11.25M
Capital Expenditures	-3,244
Free Cash Flow	-11.25M
FCF Per Share	-$2.13

Full Cash Flow Statement

Margins

Gross Margin	n/a
Operating Margin	n/a
Pretax Margin	n/a
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

PCSA does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-133.30%
Shareholder Yield	-133.30%
Earnings Yield	-607.82%
FCF Yield	-576.95%

Analyst Forecast

The average price target for PCSA is $6.00, which is 1,356.31% higher than the current price. The consensus rating is "Strong Buy".

Price Target	$6.00
Price Target Difference	1,356.31%
Analyst Consensus	Strong Buy
Analyst Count	1
Revenue Growth Forecast (5Y)	n/a
EPS Growth Forecast (5Y)	n/a

Stock Forecasts

Stock Splits

The last stock split was on January 22, 2024. It was a reverse split with a ratio of 0.05:1.

Last Split Date	Jan 22, 2024
Split Type	Reverse
Split Ratio	0.05:1

Scores

Altman Z-Score	n/a
Piotroski F-Score	1